SGRY:NGS-Surgery Partners Inc. (USD)

EQUITY | Medical Care Facilities | Nasdaq Global Select

Last Closing

USD 21.1

Change

-0.12 (-0.57)%

Market Cap

USD 0.82B

Volume

0.72M

Analyst Target

USD 21.83
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Surgery Partners Inc is a healthcare service company. It owns & operates ambulatory surgery centers providing services including anesthesia, diagnostic testing & radiation oncology.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

-0.74 (-0.55%)

USD 8.25B
OPCH Option Care Health Inc

+0.01 (+0.04%)

USD 4.00B
ACHC Acadia Healthcare Company Inc

-0.40 (-1.06%)

USD 3.78B
AMED Amedisys Inc

+0.60 (+0.71%)

USD 2.81B
LFST Lifestance Health Group Inc

-0.03 (-0.41%)

USD 2.74B
ADUS Addus HomeCare Corporation

-2.54 (-1.93%)

USD 2.27B
ASTH Astrana Health Inc

-0.23 (-0.68%)

USD 1.89B
AVAH Aveanna Healthcare Holdings In..

-0.10 (-2.18%)

USD 1.04B
HCSG Healthcare Services Group Inc

-0.18 (-1.59%)

USD 0.91B
CCRN Cross Country Healthcare Inc

-0.01 (-0.06%)

USD 0.58B

ETFs Containing SGRY

FSYD Fidelity Sustainable High.. 0.09 % 0.00 %

-0.10 (-0.21%)

USD 0.04B
NASH 0.00 % 0.49 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -34.04% 37% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -34.04% 37% F 25% F
Trailing 12 Months  
Capital Gain -34.53% 37% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -34.53% 37% F 25% F
Trailing 5 Years  
Capital Gain 36.13% 60% D- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 36.13% 60% D- 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 51.30% 85% B 87% B+
Dividend Return 51.30% 85% B 87% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 141.98% 22% F 16% F
Risk Adjusted Return 36.14% 78% C+ 67% D+
Market Capitalization 0.82B 80% B- 82% B

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 3,124.00 6% 0%
Price/Book Ratio 1.36 71% 63%
Price / Cash Flow Ratio 8.81 48% 32%
Price/Free Cash Flow Ratio 12.45 54% 30%
Management Effectiveness  
Return on Equity 3.08% 70% 63%
Return on Invested Capital 6.99% 68% 71%
Return on Assets 3.90% 64% 82%
Debt to Equity Ratio 135.96% 17% 17%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector